ストックスクリーナーアプリを入手
2.81
0.71%
-0.02
アフターアワーズ：
2.81
Annexon Inc (ANNX) 最新ニュース
Annexon executive sells shares worth $16,379 By Investing.com - Investing.com South Africa
Annexon chief medical officer sells $16,342 in common stock - Investing.com
Annexon EVP Ted Yednock sells $24,283 in stock - Investing.com
Annexon executive sells shares worth $16,379 - Investing.com
Annexon chief business officer sells $19,523 in company stock - Investing.com
Annexon EVP Ted Yednock sells $24,283 in stock By Investing.com - Investing.com South Africa
Annexon CFO Jennifer Lew sells shares worth $20,183 By Investing.com - Investing.com South Africa
Annexon CFO Jennifer Lew sells shares worth $20,183 - Investing.com
Annexon chief medical officer sells $16,342 in common stock By Investing.com - Investing.com UK
Annexon CFO Jennifer Lew Sells Shares to Cover Tax Obligations - TradingView
Annexon, Inc. (NASDAQ:ANNX) Short Interest Update - MarketBeat
Annexon, Inc. (NASDAQ:ANNX) Given Average Recommendation of "Buy" by Analysts - MarketBeat
Douglas Love Sells 5,021 Shares of Annexon, Inc. (NASDAQ:ANNX) Stock - MarketBeat
Annexon EVP sells $4,260 in stock to cover tax obligations By Investing.com - Investing.com Canada
Annexon EVP Ted Yednock sells $5,331 in stock By Investing.com - Investing.com Canada
Annexon CFO Jennifer Lew sells $5,322 in stock By Investing.com - Investing.com South Africa
Annexon EVP sells $4,260 in stock to cover tax obligations - Investing.com India
Annexon CFO Jennifer Lew sells $5,322 in stock - Investing.com India
Annexon CEO Love Douglas sells $14,811 in stock By Investing.com - Investing.com South Africa
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Employee Stock Options Alert: Annexon Awards Major Equity Package Worth $1.6M - StockTitan
Annexon stock hits 52-week low at $3.04 amid market challenges - MSN
Annexon, Inc. (NASDAQ:ANNX) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
Form 8-KCurrent report - br.ADVFN.com
Annexon's ANX007 Shows Significant Retinal Protection In Geographic Atrophy In Phase 2 Trial - Nasdaq
A look into Annexon Inc (ANNX)’s deeper side - SETE News
Annexon Announces Presentations Highlighting ANX007 - GlobeNewswire
Annexon Inc (NASDAQ: ANNX) Slashes -3.54%: What Could Be On The Way Going Forward? - Stocks Register
Revolutionary Eye Treatment ANX007 Preserves Vision in Geographic Atrophy Patients: Clinical Data Revealed - StockTitan
Critical Survey: Prothena (NASDAQ:PRTA) vs. Annexon (NASDAQ:ANNX) - Defense World
A stock that deserves closer examination: Annexon Inc (ANNX) - US Post News
Annexon Inc (ANNX) Shares Decline Despite Market Challenges - The News Heater
Check out these key findings about Annexon Inc (ANNX) - SETE News
Annexon Inc [ANNX] Investment Guide: What You Need to Know - Knox Daily
A year in review: Annexon Inc (ANNX)’s performance in the last year - US Post News
Market Update: Annexon Inc (ANNX) Sees Negative Movement, Closing at 3.52 - The Dwinnex
Analyzing the Impact of Earnings Reports on Annexon Inc Inc. (ANNX) Price Performance - The InvestChronicle
Annexon, Inc. (NASDAQ:ANNX) Short Interest Up 23.7% in January - MarketBeat
Annexon (NASDAQ:ANNX) and Tonix Pharmaceuticals (NASDAQ:TNXP) Head-To-Head Comparison - Defense World
What's Driving These Stocks Higher In After-hours? - RTTNews
Vanguard Group Inc's Strategic Acquisition of Annexon Inc Shares - GuruFocus.com
Annexon stock touches 52-week low at $3.85 amid market challenges - Investing.com Australia
Critical Survey: Day One Biopharmaceuticals (NASDAQ:DAWN) vs. Annexon (NASDAQ:ANNX) - Defense World
Annexon (ANNX) Up as Phase III Neuro Disorder Study Meets Goals - MSN
Cantor Fitzgerald Estimates Annexon FY2025 Earnings - Defense World
0.27%
3.05%
大文字化:
|
ボリューム (24 時間):